… may open new perspectives for atherosclerosis treatment. Conclusion: … targeting
antioxidant therapies appear to be promising for the development of treatment of atherosclerosis …

… atherosclerosis successfully [6]. Although lipoproteins and lipid-related factors are very
important in the pathogenesis of atherosclerosis, … trials targeting inflammation in atherosclerosis …

… The atherosclerosis field is so vast that attempts to comprehensively cover all aspects will …
atherosclerosis and to discuss clinical applications of targeting inflammation in atherosclerosis …

… to be critical and powerful modulators of immune responses in atherosclerosis. We thought
that selective targeting of signalling molecules directly downstream of CD40 such as TNF-…

In this unifying hypothesis directed to the etiology and pathogenesis of atherosclerosis, the
importance of focal arterial lesion‐prone sites has been emphasized. Key initial participants …

… and effective target sites for atherosclerosis. Therefore, the mechanism of atherosclerosis
has … may contribute to the application of STAT3 as a novel target of atherosclerosis therapies. …

… inflammatory hypothesis of atherosclerosis and cancer … pathogenesis of atherosclerotic
disease in conjunction with or beyond elevated lipid levels; however, ultimate proof by selective …

… The most devastating consequences of atherosclerosis, such … why atherosclerosis develops
but rather why atherosclerosis, … and thrombosis averted, atherosclerosis would be a much …

… Targeted disruption of the MSR gene results in the reduction of atherosclerotic lesions in
apolipoprotein E-deficient animals. Macrophages from MSR-deficient mice exhibit a marked …

… in atherosclerosis, and discuss the preclinical studies targeting these key pathways for
atherosclerosis, the clinical trials that are going to target some of … and atherosclerosis in the clinic. …